Medicare Part D coverage · 24 · RxCUI 722256
24 HR rotigotine 0.0833 MG/HR Transdermal System [Neupro]
Per the CMS 2026 Part D formulary file, 24 HR rotigotine 0.0833 MG/HR Transdermal System [Neupro] is covered by 1,702 Medicare Part D plans (33.7% of enrollable products), averaging Tier 3.4, with prior authorization required on 2.9% of covering formularies.
- 33.7%
- Plan coverage
- 1,702
- Plans covering
- T3.4
- Avg tier
- 2.9%
- Prior auth required
What the CMS Formulary Data Shows for 24 HR rotigotine 0.0833 MG/HR Transdermal System [Neupro]
Per the CMS 2026 Part D formulary file, 24 HR rotigotine 0.0833 MG/HR Transdermal System [Neupro] (RxNorm concept RXCUI 722256, generic name 24) appears on 103 distinct formulary files spanning 1,702 Medicare Part D plan offerings - 33.7% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 3.4.
Real-world access to 24 HR rotigotine 0.0833 MG/HR Transdermal System [Neupro] depends on utilization management as much as tier placement: 2.9% of covering formularies require prior authorization. 7.8% require step therapy. 26.2% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 15,325 Part D beneficiaries filled 24 HR rotigotine 0.0833 MG/HR Transdermal System [Neupro] in 2023, with total plan-and-beneficiary spending of $92,722,198 and an average per-beneficiary annual cost of $6,050.39. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry 24 HR rotigotine 0.0833 MG/HR Transdermal System [Neupro] today.
Coverage Details
- Formularies covering
- 103
- Plans covering
- 1,702
- Coverage rate
- 33.7%
- Tier range
- Tier 1 – Tier 4
- Average tier
- Tier 3, Preferred Brand
Restrictions
- Prior authorization required
- 2.9% of formularies
- Step therapy required
- 7.8% of formularies
- Quantity limits
- 26.2% of formularies
2023 Medicare Spending
- Beneficiaries
- 15,325
- Total spending
- $92,722,198
- Avg per beneficiary
- $6,050.39
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering 24 HR rotigotine 0.0833 MG/HR Transdermal System [Neupro]
100 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| ElderServe MAP (HMO D-SNP) | Elderserve Health, Inc. | T1 | No | $0 | NY |
| Cooperative Advantage (HMO D-SNP) | Group Health Cooperative OF EAU Claire | T1 | No | $0 | WI |
| Longevity Health Plan (PPO I-SNP) | Longevity Health Plan OF NEW Jersey Insurance Comp | T1 | No | $0 | NJ |
| Upper Peninsula Health Plan MI Coordinated Health (HMO D-SNP) | Upper Peninsula Health Plan, LLC | T1 | No | $0 | MI |
| CareSource Dual Advantage (HMO D-SNP) | Caresource Georgia Co. | T1 | No | $0 | GA |
| HAP CareSource MI Coordinated Health (HMO D-SNP) | HAP Caresource | T1 | No | $0 | MI |
| Gold Coast Health Plan Total Care Advantage (HMO D-SNP) | Ventura County Medi-Cal Managed Care Commission | T1 | No | $0 | CA |
| Blue Cross Medicare Advantage Dual Care Plus (HMO D-SNP) | Health Care Service Corporation | T1 | No | $0 | NM |
| Blue Cross MA Dual Care Plus Preferred (PPO D-SNP) | Health Care Service Corporation | T1 | No | $0 | NM |
| SecureBlue (HMO D-SNP) | HMO Minnesota | T1 | No | $0 | MN |
| Hamaspik Medicare Choice (HMO D-SNP) | Hamaspik, Inc. | T1 | No | $0 | NY |
| SeniorCare Complete (HMO D-SNP) | South Country Health Alliance | T1 | No | $0 | MN |
| AbilityCare (HMO D-SNP) | South Country Health Alliance | T1 | No | $0 | MN |
| Alameda Alliance Wellness (HMO D-SNP) | Alameda Alliance FOR Health | T1 | No | $0 | CA |
| Community Care's Partnership Program (HMO D-SNP) | Community Care Health Plan, Inc. | T1 | No | $0 | WI |
| Platino Blindao (HMO D-SNP) | Triple S Advantage, Inc. | T1 | Yes | $0 | PR |
| Platino Enlace (HMO D-SNP) | Triple S Advantage, Inc. | T1 | Yes | $0 | PR |
| Platino Advance (HMO D-snp) | Triple S Advantage, Inc. | T1 | Yes | $0 | PR |
| Platino Plus (HMO D-snp) | Triple S Advantage, Inc. | T1 | Yes | $0 | PR |
| Longevity Health Plan (HMO I-SNP) | Longevity Health Plan OF Florida, Inc. | T1 | No | $4.80 | FL |
Show the next 30 plans
| Blue Cross Medicare Advantage Dual Care Plus (HMO D-SNP) | Hcsc Insurance Services Company | T1 | No | $4.80 | TX |
| Gold Dialysis & Kidney Complete (HMO-POS C-SNP) | Gold Kidney OF Florida Inc | T1 | No | $4.80 | FL |
| Blue Cross Medicare Advantage Dual Care Plus (HMO D-SNP) | GHS Insurance Company | T1 | No | $5.00 | OK |
| Longevity Health Plan (HMO I-SNP) | Longevity Health Plan OF Michigan, Inc. | T1 | No | $8.80 | MI |
| Longevity Health Plan (HMO I-SNP) | Longevity Health Plan OF Illinois, Inc. | T1 | No | $15.20 | IL |
| Gold Dialysis & Kidney Complete (HMO-POS C-SNP) | Gold Kidney OF Arizona | T1 | No | $17.00 | AZ |
| WellSense Added Value (HMO) | Boston Medical Center Health Plan, Inc. | T1 | No | $21.70 | NH |
| Hamaspik Medicare Select (HMO D-SNP) | Hamaspik, Inc. | T1 | No | $34.50 | NY |
| Longevity Health Plan (HMO I-SNP) | Longevity Health Plan OF Colorado, Inc. | T1 | No | $35.20 | CO |
| Longevity Health Plan (HMO I-SNP) | Longevity Health Plan OF North Carolina, Inc. | T1 | No | $36.20 | NC |
| Longevity Health Plan (PPO I-SNP) | Longevity Health Plan OF NEW Jersey Insurance Comp | T1 | No | $40.00 | NJ |
| ElderServe Star (HMO I-SNP) | Elderserve Health, Inc. | T1 | No | $58.80 | NY |
| Longevity Health Plan (HMO I-SNP) | Longevity Health Plan OF NEW York, Inc. | T1 | No | $58.80 | NY |
| CareAdvantage (HMO D-SNP) | SAN Mateo Health Commission | T2 | No | $0 | CA |
| CalOptima Health OneCare Complete (HMO D-SNP) | Orange County Health Authority | T2 | No | $0 | CA |
| Leon MediExtra (HMO) | Leon Health, Inc. | T2 | No | $0 | FL |
| Leon MediDual (HMO D-SNP) | Leon Health, Inc. | T2 | No | $0 | FL |
| Leon MediMore (HMO) | Leon Health, Inc. | T2 | No | $0 | FL |
| Leon MediMax (HMO D-SNP) | Leon Health, Inc. | T2 | No | $0 | FL |
| Freedom VIP Care (HMO C-SNP) | Freedom Health, Inc. | T3 | No | $0 | FL |
| Freedom VIP Savings (HMO C-SNP) | Freedom Health, Inc. | T3 | No | $0 | FL |
| Freedom VIP Savings (HMO C-SNP) | Freedom Health, Inc. | T3 | No | $0 | FL |
| Freedom VIP Rewards (HMO C-SNP) | Freedom Health, Inc. | T3 | No | $0 | FL |
| Freedom VIP Rewards (HMO C-SNP) | Freedom Health, Inc. | T3 | No | $0 | FL |
| Optimum Diamond Rewards (HMO C-SNP) | Optimum Healthcare, Inc. | T3 | No | $0 | FL |
| Optimum Diamond Savings (HMO C-SNP) | Optimum Healthcare, Inc. | T3 | No | $0 | FL |
| Optimum Diamond Rewards (HMO C-SNP) | Optimum Healthcare, Inc. | T3 | No | $0 | FL |
| Optimum Diamond (HMO C-SNP) | Optimum Healthcare, Inc. | T3 | No | $0 | FL |
| Freedom Medi-Medi Partial (HMO D-SNP) | Freedom Health, Inc. | T3 | No | $0 | FL |
| Freedom Medi-Medi Full (HMO D-SNP) | Freedom Health, Inc. | T3 | No | $0 | FL |
Showing top 50 of 100 plans.
Frequently Asked Questions
Is 24 HR rotigotine 0.0833 MG/HR Transdermal System [Neupro] covered by Medicare Part D?
Yes, 24 HR rotigotine 0.0833 MG/HR Transdermal System [Neupro] is covered by 1,702 Medicare Part D plans (33.7% of all Part D formularies).
What tier is 24 HR rotigotine 0.0833 MG/HR Transdermal System [Neupro] on Medicare Part D plans?
24 HR rotigotine 0.0833 MG/HR Transdermal System [Neupro] averages Tier 3.4 across Part D plans, ranging from Tier 1 to Tier 4.
Does 24 HR rotigotine 0.0833 MG/HR Transdermal System [Neupro] require prior authorization?
2.9% of Part D formularies require prior authorization for 24 HR rotigotine 0.0833 MG/HR Transdermal System [Neupro]. Step therapy: 7.8%. Quantity limits: 26.2%.
How much does Medicare spend on 24 HR rotigotine 0.0833 MG/HR Transdermal System [Neupro]?
In 2023, total Medicare Part D spending on 24 HR rotigotine 0.0833 MG/HR Transdermal System [Neupro] was $92,722,198, covering 15,325 beneficiaries. The average spend per beneficiary was $6,050.39.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
- 1 ML penicillin G benzathine 600000 UNT/ML Prefilled Syringe [Bicillin L-A] T3.4
- levetiracetam 250 MG Tablet for Oral Suspension [Spritam] T3.4
- teriflunomide 14 MG Oral Tablet T3.4
- auranofin 3 MG Oral Capsule [Ridaura] T3.4
- colistin 75 MG/ML Injectable Solution T3.4
- 4 ML penicillin G benzathine 600000 UNT/ML Prefilled Syringe [Bicillin L-A] T3.4
Similar prior-authorization rate
- topiramate 50 MG Oral Capsule 2.9% PA
- gepotidacin 750 MG Oral Tablet [Blujepa] 2.9% PA
- sevelamer hydrochloride 800 MG Oral Tablet 3% PA
- 50/50 Release 24 HR methylphenidate hydrochloride 30 MG Extended Release Oral Capsule 3% PA
- hydroxyurea 200 MG Oral Capsule [Droxia] 2.8% PA
- phenytoin sodium 30 MG Extended Release Oral Capsule [Dilantin] 3% PA